MTOR and carpal tunnel syndrome: We further showed that PI3K/Akt/mTOR signaling pathway is an important therapeutic target and that AMPK activation might be an effective therapeutic approach to improve the SSCT fibrosis in CTS patients rather than targeting PI3K inhibition alone (Fig. 5).